Risultati della ricerca - Rotshteyn, Yakov

Pharmacokinetic and pharmacodynamic profile following oral administration of the phosphodiesterase (PDE)4 inhibitor V11294A in healthy volunteers di Gale, Donna Donigi, Landells, Linda J, Spina, Domenico, Miller, Alan J, Smith, Kate, Nichols, Terry, Rotshteyn, Yakov, Tonelli, Alfred, Lacouture, Peter, Burch, Ronald M, Page, Clive P, O'Connor, Brian J

Testo Testo Testo

Anti-HIV-1 Activity of Weekly or Biweekly Treatment with Subcutaneous PRO 140, a CCR5 Monoclonal Antibody di Jacobson, Jeffrey M., Thompson, Melanie A., Lalezari, Jacob P., Saag, Michael S., Zingman, Barry S., D’Ambrosio, Paul, Stambler, Nancy, Rotshteyn, Yakov, Marozsan, Andre J., Maddon, Paul J., Morris, Stephen A., Olson, William C.

Testo Testo Testo

Novel Small-Molecule Inhibitors of Hepatitis C Virus Entry Block Viral Spread and Promote Viral Clearance in Cell Culture di Coburn, Glen A., Fisch, Danielle N., Moorji, Sameer M., de Muys, Jean-Marc, Murga, Jose D., Paul, Dorothy, Provoncha, Kathleen P., Rotshteyn, Yakov, Han, Amy Q., Qian, Dapeng, Maddon, Paul J., Olson, William C.

Testo Testo Testo

Phase 2a Study of the CCR5 Monoclonal Antibody PRO 140 Administered Intravenously to HIV-Infected Adults di Jacobson, Jeffrey M., Lalezari, Jacob P., Thompson, Melanie A., Fichtenbaum, Carl J., Saag, Michael S., Zingman, Barry S., D'Ambrosio, Paul, Stambler, Nancy, Rotshteyn, Yakov, Marozsan, Andre J., Maddon, Paul J., Morris, Stephen A., Olson, William C.

Testo Testo Testo